Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System

被引:8
|
作者
Wong, Jessie J. [1 ]
Hood, Korey K. [1 ,2 ]
Hanes, Sarah J. [1 ]
Lal, Rayhan A. [1 ,2 ,3 ]
Naranjo, Diana [1 ,2 ]
机构
[1] Stanford Univ, Div Endocrinol & Diabet, Dept Pediat, Sch Med, Stanford, CA USA
[2] Stanford Univ, Stanford Diabet Res Ctr, Sch Med, Stanford, CA USA
[3] Stanford Univ, Div Endocrinol Gerontol & Metab, Dept Med, Sch Med, Stanford, CA USA
来源
关键词
diabetes mellitus; type; 1; drug therapy; insulin; administration; dosage; automation; DIABETES DISTRESS; GLYCEMIC CONTROL; MANAGEMENT; DEPRESSION; STATEMENT; SEARCH; PEOPLE; CARE;
D O I
10.1177/19322968221105288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: This study examined the psychosocial impact of Loop, an open-source automated insulin dosing system that has emerged from the diabetes technology "Do-It-Yourself" (DIY) movement. Methods: Subsamples of 239 adults, 115 children, and 243 parents completed data collection at the time of Loop initiation and 3 and 6 months later. Surveys collected demographic and clinical information, percent time-in-range, HbA1c, and validated psychosocial measures. Analyses included paired t tests and McNemar's tests to compare psychosocial functioning at 3 and 6 months and regression models to assess baseline predictors of psychosocial outcomes at 6 months. Results: Adults reported significant improvements in diabetes distress (t = -7.20 P < .001; t = -8.01, P < .001), sleep quality (t = 6.81, P < .001; t = 2.98, P = .003), fear of hypoglycemia (t = -4.42, P < .001; t = -4.97, P < .001), and hypoglycemia confidence (t = 8.68, P < .001; t = 7.96 P < .001) from baseline to 3 months and 6 months, respectively. Significant improvements in parents' and children's sleep quality and parents' fear of hypoglycemia were also observed. Several baseline characteristics were associated with psychosocial outcomes at 6 months. Conclusions: The current findings support the broad and sustained benefits of Loop across multiple aspects of psychosocial well-being. Advancement and dissemination of such technologies has the potential to improve mental and physiological health among people living with type 1 diabetes.
引用
收藏
页码:1440 / 1447
页数:8
相关论文
共 50 条
  • [21] Efficacy and safety of an open-source automated insulin delivery system over 48 weeks of use in the CREATE randomised controlled trial
    Burnside, M. J.
    Lewis, D. M.
    Crocket, H. R.
    Meier, R. A.
    Williman, J. A.
    Jefferies, C. A.
    Faherty, A. M.
    Paul, R. G.
    Lever, C. S.
    Price, S. K. J.
    Frewen, C. M.
    Jones, S. D.
    Gunn, T. C.
    Wheeler, B. J.
    de Bock, M. I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S349 - S349
  • [22] CREATE (COMMUNITY DERIVED AUTOMATED INSULIN DELIVERY): RANDOMISED TRIAL COMPARING AUTOMATED INSULIN DELIVERY (ANYDANA-LOOP) USING OPEN-SOURCE ALGORITHM, WITH SENSOR AUGMENTED PUMP THERAPY IN TYPE 1 DIABETES
    Burnside, M.
    De Bock, M.
    Williman, J.
    Lewis, D.
    Jefferies, C.
    Crocket, H.
    Wheeler, B.
    Paul, R.
    Wilson, R.
    Sanders, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A74 - A74
  • [23] Psychosocial Outcomes among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Findings from an International Survey of Adults with Type 1 Diabetes
    Schipp, Jasmine
    Hendrieckx, Christel
    Braune, Katarina
    O'Donnell, Shane
    Ballhausen, Hanne
    Cleal, Bryan
    Waldchen, Mandy
    Knoll, Christine
    Gajewska, Katarzyna A.
    Skinner, Timothy C.
    Speight, Jane
    DIABETES, 2022, 71
  • [24] Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems
    Shahid, Arsalan
    Lewis, Dana M.
    NUTRIENTS, 2022, 14 (09)
  • [25] Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals
    Braune, Katarina
    Lal, Rayhan A.
    Petruzelkova, Lenka
    Scheiner, Gary
    Winterdijk, Per
    Schmidt, Signe
    Raimond, Linda
    Hood, Korey K.
    Riddell, Michael C.
    Skinner, Timothy C.
    Raile, Klemens
    Hussain, Sufyan
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (01): : 58 - 74
  • [26] Efficacy of open-source automated insulin delivery systems compared with commercial hybrid closed-loop insulin pumps: real-world data from a tertiary center
    Horvath, L.
    Mraz, M.
    Klouckova, J.
    Vavra, D.
    Bem, R.
    Haluzik, M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S386 - S387
  • [27] A System for Automated Open-Source Threat Intelligence Gathering and Management
    Gao, Peng
    Liu, Xiaoyuan
    Choi, Edward
    Soman, Bhavna
    Mishra, Chinmaya
    Farris, Kate
    Song, Dawn
    SIGMOD '21: PROCEEDINGS OF THE 2021 INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, 2021, : 2716 - 2720
  • [28] A NEW OPEN-LOOP INSULIN DELIVERY SYSTEM
    SIPOSS, GG
    DAVIDSON, MB
    MEDICAL INSTRUMENTATION, 1981, 15 (05): : 338 - 340
  • [29] First Use of Open-Source Automated Insulin Delivery AndroidAPS in Full Closed-Loop Scenario; Pancreas4ALL Randomized Pilot Study
    Petruzelkova, Lenka
    Neuman, Vit
    Plachy, Lukas
    Kozak, Milos
    Obermannova, Barbora
    Kolouskova, Stanislava
    Pruhova, Stepanka
    Sumnik, Zdenek
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (05) : 315 - 323
  • [30] Management of Type 1 Diabetes Mellitus Using Open-Source Automated Insulin Delivery During Pregnancy: A Case Series
    Schuetz, Anna K.
    Schuetz-Fuhrmann, Ingrid
    Stadler, Marietta
    Staudinger, Hannah
    Mader, Julia K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (03) : 227 - 230